Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. I. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. J.A.M.A., 202: 1028, 1967.
2.
Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressures averaging 90 through 114 mm Hg. J.A.M.A., 213: 1143, 1970 .
3.
Abernethy, J.D. : The Australian national blood pressure study . Med. J. Aust., 1: 821, 1974.
4.
Beevers, D.G. , Fairman, M.J., Hamilton , M., et al.: Antihypertensive treatment and the course of established cerebral vascular disease. Lancet, 1: 1407, 1973.
5.
Harrington, M., Kincaid-Smith, P.McMichael , J.: Results of treatment in malignant hypertension . Br. Med. J., 2: 969, 1959.
6.
Dahl, L.K.: Salt and hypertension. Am. J. Clin. Nutr., 25: 231, 1972.
7.
Parijs, J., Joosens, J.V., Vander Linden, L., et al.: Moderate sodium restriction and diuretics in the treatment of hypertension. Am. Heart J., 85: 22, 1973.
8.
Bjerkedahl, T.: Overweight and hypertension. Acta Med. Scand., 159: 13, 1957.
9.
Epstein, F.H. , Francis, T., Jr., Hayner, N.S., et al.: Prevalence of chronic diseases and distribution of selected physiologic variables in a total community, Tecumseh, Michigan. Am. J. Epidemiol., 81: 307, 1965.
10.
Kilbom, Å. , Hartley, L.H., Saltin, B., et al.: Physical training in sedentary middle-aged and older men. I. Medical evaluation. Scand. J. clin. Lab. Invest., 24: 315, 1969.
11.
Ambard, L., Beaujard, E.: Causes de l'hypertension arterielle. Arch. Gen. Med. , 1: 520, 1904.
12.
Kempner, W. : Treatment of hypertensive vascular disease with rice diet. Am. J. Med., 4: 545, 1948.
13.
Freis, E.D. : Salt, volume and the prevention of hypertension . Circulation, 53: 589, 1976.
14.
Thulin, T.: Validity of casual blood pressure in females. Acta. Med, Scand. , In press.
15.
Thulin, T., Werner, O.: Exercise test and 24 hour heart rate recording in males with high and low casual blood pressure levels. Br. Heart J. In press.
16.
Thulin, T., Bengtsson, B., Scherstén, B.: Assessment of casual blood pressure variations. Postgrad Med. J., In press.
17.
Dawber, T.R. , Kannel, W.B., Kagan, A., et al.: Environmental factors in hypertension , in The Epidemiology of Hypertension. Edited by J. Stamler, R. Stamler, T. N.Pullman. New York: Grune & Stratton, 1967.
18.
Chiang, B.H. , Perlman, L.V., Epstein , F.H.: Overweight and hypertension. A review. Circulation, 39: 403, 1969.
19.
Zilva, J.F. , Nicholson, J.P.: An obesity index and the significance of bromide space measurements. Clin. Sci., 19: 449, 1960.
Barrat-Boyes, B.G., Wood, E.H.: Cardiac output and related measurements and pressure values in the right heart and associated vessels, together with an analysis of the hemodynamic response to the inhalation of high oxygen mixtures in healthy subjects. J. Lab. Clin. Med., 51: 72, 1958.
22.
Brožek, J., Grande, F., Anderson , J.T., et al.: Densitometric analysis of body composition: Revision of some quantitative assumptions. Ann. N. Y. Acad. Sci., 110: 113, 1963.
23.
Larsen, O.A. , Lassen, N.A., Quaade , F.: Blood flow through human adipose tissue determined with radioactive xenon. Acta Physiol. Scand., 63: 337, 1966.
24.
Frick, M.H. : Coronary implications of hemodynamic changes caused by physical training. Am. J. Cardiol., 22: 417, 1969.
25.
Melander, A. , Danielson, K., Hanson , A., et al.: Enhancement of hydralazine bioavailability by concomitant intake of food. Clin Pharmacol. Ther., 22: 104, 1977.
26.
Melander, A. , Danielson, K., Scherstén , B., et al.: Enhancement by concomitant food intake of cancrenone bioavailability upon administration of spironolactone. Clin. Pharmacol. Ther., 22: 100, 1977.
27.
Melander, A. , Danielson, K., Scherstén , B. et al.: Enhancement of the bioavailability of propranolol and metoprolol by concomitant intake of food. Clin Pharmacol. Ther., 22: 108, 1977.
28.
Page, I.H.: Pathogenesis of arterial hypertension. J.A.M.A., 140: 451, 1949.
29.
Bühler, F.R. , Laragh, J.H., Baer . L., et al.: Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. New Engl. J. Med. , 287: 1209, 1972 .
30.
Laragh, J.H. : Modern system for treatment of high blood pressure based on renin profiling and vasoconstriction-volume analysis: A primary role for beta blocking drugs such as propranolol. Am. J. Med., 61: 797, 1976.
31.
Karlberg, B.E. , Kågedahl, B., Tegler , L., et al.: Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity. Am. J. Cardiol.37: 642, 1976.
32.
Karlberg, B.E. , Thulin, T.: Treatment of primary hypertension with atenolol. A study with special reference to initial plasma renin activity . Submitted for publication.